METHYL 4-BROMO-2,2-DIMETHYL-3-OXOBUTANOATE, 95.0%, 1g

cis-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol, 98%, 50mg

2-(2-Chloropyridin-3-yl)-2-methylpropanoic acid, 95%, 250mg

(Benzenesulfonyl)acetamide oxime, 95.0%, 5g

3-Iodobiphenyl>98.0%(GC)5g

2,4-Diphenyl-6-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidine, 98%, 25g

2-Bromo-4-chloro-5-methoxy-benzoic acid, 95.0%, 1g

Plan phase PLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

7-Chloro-1H-indazole, 97.0%, 10g

3,3-Dimethoxycyclobutan-1-ol, 97%, 100mg

3',5'-Difluoro-[1,1'-biphenyl]-4-amine, 95.0%, 250mg

METHYL 3-BROMOINDOLE-5-CARBOXYLATE, 95.0%, 10g

2-Boc-2,8-Diazaspiro[5.5]undecane, 95.0%, 250mg